Drugs and Devices

FDA approves new drug for eczema

On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares